Best practice

HIV treatment supplied at cost price to public HIV and international donor programmes

GSK and ViiV Healthcare improve patient access to a first-line HIV/AIDS therapy

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |